2021 annual financial data
Indaptus Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -7,729,108 USD and net income was -7,711,386 USD.
Operating cash flow was -11,290,535 USD.
Get free Indaptus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,729,108 USD
- Net income
- -7,711,386 USD
- Operating cash flow
- -11,290,535 USD